{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:47:43Z","timestamp":1790740063646,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41589-018-0222-1","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T17:03:58Z","timestamp":1548695038000},"page":"304-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-8490","authenticated-orcid":false,"given":"Jean","family":"Quancard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8061-9353","authenticated-orcid":false,"given":"Theo","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Yu","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7348-2915","authenticated-orcid":false,"given":"Martin","family":"Renatus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-8558","authenticated-orcid":false,"given":"Nicola","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4385-6517","authenticated-orcid":false,"given":"Laura","family":"Isra\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8794-6306","authenticated-orcid":false,"given":"John J.","family":"Priatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyeong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-5545","authenticated-orcid":false,"given":"Rosa I.","family":"Viner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-1371","authenticated-orcid":false,"given":"Jutta","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-8889","authenticated-orcid":false,"given":"Achim","family":"Schlapbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-3445","authenticated-orcid":false,"given":"Paul","family":"Erbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7688-7574","authenticated-orcid":false,"given":"Jayachandran","family":"Kizhakkedathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Hersperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1599-1065","authenticated-orcid":false,"given":"Stuart E.","family":"Turvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7152-8417","authenticated-orcid":false,"given":"Joerg","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0152-6720","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Bornancin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-2731","authenticated-orcid":false,"given":"Christopher M.","family":"Overall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"222_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrd2092","volume":"5","author":"B Turk","year":"2006","unstructured":"Turk, B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug. Discov. 5, 785\u2013799 (2006).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"222_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall, C. M. & Kleifeld, O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6, 227\u2013239 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"222_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/acs.chemrev.7b00120","volume":"118","author":"T Klein","year":"2018","unstructured":"Klein, T., Eckhard, U., Dufour, A., Solis, N. & Overall, C. M. Proteolytic cleavage-mechanisms, function, and \u201comic\u201d approaches for a near-ubiquitous posttranslational modification. Chem. Rev. 118, 1137\u20131168 (2018).","journal-title":"Chem. Rev."},{"key":"222_CR4","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.2174\/1568026611212220002","volume":"12","author":"CM Gomes","year":"2012","unstructured":"Gomes, C. M. Protein misfolding in disease and small molecule therapies. Curr. Top. Med. Chem. 12, 2460\u20132469 (2012).","journal-title":"Curr. Top. Med. Chem."},{"key":"222_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/cge.13088","volume":"93","author":"A G\u00e1mez","year":"2018","unstructured":"G\u00e1mez, A. et al. Protein misfolding diseases: prospects of pharmacological treatment. Clin. Genet. 93, 450\u2013458 (2018).","journal-title":"Clin. Genet."},{"key":"222_CR6","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.ddtec.2014.03.009","volume":"12","author":"EL Rudashevskaya","year":"2014","unstructured":"Rudashevskaya, E. L., Stockner, T., Trauner, M., Freissmuth, M. & Chiba, P. Pharmacological correction of misfolding of ABC proteins. Drug Discov. Today. Technol. 12, e87\u2013e94 (2014).","journal-title":"Drug Discov. Today. Technol."},{"key":"222_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.143","volume":"6","author":"N Mohell","year":"2015","unstructured":"Mohell, N. et al. APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells. Cell Death Dis. 6, e1794 (2015).","journal-title":"Cell Death Dis."},{"key":"222_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nchembio850","volume":"3","author":"RL Lieberman","year":"2007","unstructured":"Lieberman, R. L. et al. Structure of acid \u03b2-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nat. Chem. Biol. 3, 101\u2013107 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"222_CR9","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1093\/hmg\/ddt217","volume":"22","author":"A Jorge-Finnigan","year":"2013","unstructured":"Jorge-Finnigan, A. et al. Pharmacological chaperones as a potential therapeutic option in methylmalonic aciduria cblB type. Hum. Mol. Genet. 22, 3680\u20133689 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"222_CR10","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.bmcl.2013.01.089","volume":"23","author":"RA Denny","year":"2013","unstructured":"Denny, R. A., Gavrin, L. K. & Saiah, E. Recent developments in targeting protein misfolding diseases. Bioorg. Med. Chem. Lett. 23, 1935\u20131944 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"222_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden, M. S. & Ghosh, S. NF-\u03baB in immunobiology. Cell Res. 21, 223\u2013244 (2011).","journal-title":"Cell Res."},{"key":"222_CR12","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4161\/cc.10.15.16923","volume":"10","author":"S Rosebeck","year":"2011","unstructured":"Rosebeck, S., Rehman, A. O., Lucas, P. C. & Mcallister-lucas, L. M. From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle 10, 2485\u20132496 (2011).","journal-title":"Cell Cycle"},{"key":"222_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","volume":"14","author":"L Sun","year":"2004","unstructured":"Sun, L., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289\u2013301 (2004).","journal-title":"Mol. Cell"},{"key":"222_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ni1568","volume":"9","author":"F Rebeaud","year":"2008","unstructured":"Rebeaud, F. et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 9, 272\u2013281 (2008).","journal-title":"Nat. Immunol."},{"key":"222_CR15","doi-asserted-by":"publisher","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","volume":"182","author":"M D\u00fcwel","year":"2009","unstructured":"D\u00fcwel, M. et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J. Immunol. 182, 7718\u20137728 (2009).","journal-title":"J. Immunol."},{"key":"222_CR16","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1073\/pnas.1105020108","volume":"108","author":"S Hailfinger","year":"2011","unstructured":"Hailfinger, S. et al. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc. Natl Acad. Sci. USA 108, 14596\u201314601 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"222_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9777","volume":"6","author":"T Klein","year":"2015","unstructured":"Klein, T. et al. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-\u03baB signalling. Nat. Commun. 6, 8777 (2015).","journal-title":"Nat. Commun."},{"key":"222_CR18","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.4049\/jimmunol.1402254","volume":"194","author":"F Bornancin","year":"2015","unstructured":"Bornancin, F. et al. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation. J. Immunol. 194, 3723\u20133734 (2015).","journal-title":"J. Immunol."},{"key":"222_CR19","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","volume":"9","author":"A Gewies","year":"2014","unstructured":"Gewies, A. et al. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. Cell Rep. 9, 1292\u20131305 (2014).","journal-title":"Cell Rep."},{"key":"222_CR20","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.15252\/embj.201488987","volume":"33","author":"M Jaworski","year":"2014","unstructured":"Jaworski, M. et al. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. EMBO J. 33, 2765\u20132781 (2014).","journal-title":"EMBO J."},{"key":"222_CR21","doi-asserted-by":"publisher","first-page":"e0127083","DOI":"10.1371\/journal.pone.0127083","volume":"10","author":"JW Yu","year":"2015","unstructured":"Yu, J. W. et al. MALT1 protease activity is required for innate and adaptive immune responses. PLoS One 10, e0127083 (2015).","journal-title":"PLoS One"},{"key":"222_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molcel.2013.08.032","volume":"51","author":"Q Qiao","year":"2013","unstructured":"Qiao, Q. et al. Structural architecture of the CARMA1\/Bcl10\/MALT1 signalosome: nucleation-induced filamentous assembly. Mol. Cell 51, 766\u2013779 (2013).","journal-title":"Mol. Cell"},{"key":"222_CR23","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/emboj.2011.85","volume":"30","author":"J Staal","year":"2011","unstructured":"Staal, J. et al. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J. 30, 1742\u20131752 (2011).","journal-title":"EMBO J."},{"key":"222_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ni1561","volume":"9","author":"B Coornaert","year":"2008","unstructured":"Coornaert, B. et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 9, 263\u2013271 (2008).","journal-title":"Nat. Immunol."},{"key":"222_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/febs.13597","volume":"283","author":"L Elton","year":"2016","unstructured":"Elton, L. et al. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-\u03baB signaling. FEBS. J. 283, 403\u2013412 (2016).","journal-title":"FEBS. J."},{"key":"222_CR26","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1242\/jcs.185025","volume":"129","author":"T Douanne","year":"2016","unstructured":"Douanne, T., Gavard, J. & Bid\u00e8re, N. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling. J. Cell. Sci. 129, 1775\u20131780 (2016).","journal-title":"J. Cell. Sci."},{"key":"222_CR27","doi-asserted-by":"publisher","first-page":"e0169026","DOI":"10.1371\/journal.pone.0169026","volume":"12","author":"S Ginster","year":"2017","unstructured":"Ginster, S. et al. Two Antagonistic MALT1 auto-cleavage mechanisms reveal a role for TRAF6 to unleash MALT1 activation. PLoS One 12, e0169026 (2017).","journal-title":"PLoS One"},{"key":"222_CR28","doi-asserted-by":"publisher","first-page":"19946","DOI":"10.1073\/pnas.0907511106","volume":"106","author":"S Hailfinger","year":"2009","unstructured":"Hailfinger, S. et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc. Natl Acad. Sci. USA 106, 19946\u201319951 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"222_CR29","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1084\/jem.20091167","volume":"206","author":"U Ferch","year":"2009","unstructured":"Ferch, U. et al. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 206, 2313\u20132320 (2009).","journal-title":"J. Exp. Med."},{"key":"222_CR30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel, D. et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell. 22, 825\u2013837 (2012).","journal-title":"Cancer Cell."},{"key":"222_CR31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","volume":"22","author":"L Fontan","year":"2012","unstructured":"Fontan, L. et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell. 22, 812\u2013824 (2012).","journal-title":"Cancer Cell."},{"key":"222_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaci.2014.06.015","volume":"134","author":"SE Turvey","year":"2014","unstructured":"Turvey, S. E. et al. TheCARD11-BCL10-MALT1 (CBM) signalosome complex: stepping into the limelight of human primary immunodeficiency. J. Allergy Clin. Immunol. 134, 276\u2013284 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"222_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jaci.2015.06.031","volume":"136","author":"R P\u00e9rez de Diego","year":"2015","unstructured":"P\u00e9rez de Diego, R. et al. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: molecular, immunologic, and clinical heterogeneity. J. Allergy Clin. Immunol. 136, 1139\u20131149 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"222_CR34","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jaci.2013.10.045","volume":"133","author":"ML McKinnon","year":"2014","unstructured":"McKinnon, M. L. et al. Combined immunodeficiency associated with homozygous MALT1 mutations. J. Allergy Clin. Immunol. 133, 1458\u20131462 (2014). 1462.e1\u20131462.e7.","journal-title":"J. Allergy Clin. Immunol."},{"key":"222_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10875-014-0125-1","volume":"35","author":"D Punwani","year":"2015","unstructured":"Punwani, D. et al. Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation. J. Clin. Immunol. 35, 135\u2013146 (2015).","journal-title":"J. Clin. Immunol."},{"key":"222_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MPG.0000000000001262","volume":"64","author":"F Charbit-Henrion","year":"2017","unstructured":"Charbit-Henrion, F. et al. Deficiency in mucosa-associated lymphoid tissue lymphoma translocation 1: a novel cause of IPEX-like syndrome. J. Pediatr. Gastroenterol. Nutr. 64, 378\u2013384 (2017).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"222_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2016.04.011","volume":"168","author":"J Rozmus","year":"2016","unstructured":"Rozmus, J. et al. Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation. Clin. Immunol. 168, 1\u20135 (2016).","journal-title":"Clin. Immunol."},{"key":"222_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmb.2012.02.018","volume":"419","author":"C Wiesmann","year":"2012","unstructured":"Wiesmann, C. et al. Structural determinants of MALT1 protease activity. J. Mol. Biol. 419, 4\u201321 (2012).","journal-title":"J. Mol. Biol."},{"key":"222_CR39","doi-asserted-by":"publisher","first-page":"10384","DOI":"10.1002\/anie.201304290","volume":"52","author":"F Schlauderer","year":"2013","unstructured":"Schlauderer, F. et al. Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase. Angew. Chem. Int. Ed. Engl. 52, 10384\u201310387 (2013).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"222_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nbt.1611","volume":"28","author":"O Kleifeld","year":"2010","unstructured":"Kleifeld, O. et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat. Biotechnol. 28, 281\u2013288 (2010).","journal-title":"Nat. Biotechnol."},{"key":"222_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/imcb.1018","volume":"96","author":"M Bardet","year":"2018","unstructured":"Bardet, M. et al. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition. Immunol. Cell Biol. 96, 81\u201399 (2018).","journal-title":"Immunol. Cell Biol."},{"key":"222_CR42","doi-asserted-by":"publisher","first-page":"21004","DOI":"10.1073\/pnas.1111708108","volume":"108","author":"JW Yu","year":"2011","unstructured":"Yu, J. W., Jeffrey, P. D., Ha, J. Y., Yang, X. & Shi, Y. Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region. Proc. Natl Acad. Sci. USA 108, 21004\u201321009 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"222_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molmed.2015.12.004","volume":"22","author":"A Demeyer","year":"2016","unstructured":"Demeyer, A., Staal, J. & Beyaert, R. Targeting MALT1 proteolytic activity in immunity, inflammation and disease: good or bad? Trends Mol. Med. 22, 135\u2013150 (2016).","journal-title":"Trends Mol. Med."},{"key":"222_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"222_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1107\/S0907444903028956","volume":"60","author":"LC Storoni","year":"2004","unstructured":"Storoni, L. C., McCoy, A. J. & Read, R. J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D Biol. Crystallogr. 60, 432\u2013438 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"222_CR46","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"222_CR47","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/blood-2013-01-480665","volume":"122","author":"BK Chung","year":"2013","unstructured":"Chung, B. K. et al. Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood 122, 2600\u20132608 (2013).","journal-title":"Blood"},{"key":"222_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1073\/pnas.70.1.190","volume":"70","author":"G Miller","year":"1973","unstructured":"Miller, G. & Lipman, M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl Acad. Sci. USA 70, 190\u2013194 (1973).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"222_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis, R. E. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88\u201392 (2010).","journal-title":"Nature"},{"key":"222_CR50","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.bmcl.2018.05.017","volume":"28","author":"A Schlapbach","year":"2018","unstructured":"Schlapbach, A. et al. N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity. Bioorg. Med. Chem. Lett. 28, 2153\u20132158 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"222_CR51","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1098\/rsta.2015.0372","volume":"374","author":"T Klein","year":"2016","unstructured":"Klein, T., Viner, R. I. & Overall, C. M. Quantitative proteomics and terminomics to elucidate the role of ubiquitination and proteolysis in adaptive immunity. Philos. Trans. A Math. Phys. Eng. Sci. 374, 2079 (2016).","journal-title":"Philos. Trans. A Math. Phys. Eng. Sci."},{"key":"222_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/jpet.109.153205","volume":"330","author":"JP Evenou","year":"2009","unstructured":"Evenou, J.-P. et al. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. J. Pharmacol. Exp. Ther. 330, 792\u2013801 (2009).","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0222-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:26:57Z","timestamp":1684621617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-018-0222-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1038\/s41589-018-0222-1","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"12 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Q., M.R., N.H., L.I., J.B., A.S., P.E., F.V., R.H., J.E., and F.B. are employees of the Novartis Institute of Biomedical Research. R.I.V. is and M.B. was an employee of Thermo Fisher Scientific, developer and distributor of the Orbitrap Fusion Lumos mass spectrometer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}